The Effect of Ongoing Beta-blockers Administration on Analgesic Requirements in the Immediate Perioperative Period.
Nociceptive Pain
About this trial
This is an interventional other trial for Nociceptive Pain focused on measuring Beta adrenergic receptor blockers, Analgesia nociceptive index, Total hip replacement, Total knee replacement
Eligibility Criteria
Inclusion Criteria:
- Candidates for an elective hip replacement.
Exclusion Criteria:
- Patients with no sinus rhythm.
- Patients with an internal cardiac device / cardiac pacemaker.
- The use of Anti muscarinic, alpha adrenergic receptor blockers or anti arhythmic medications.
- Chronic use of Opioids (defined as 20 mg or more of Oxycodone per day for a period of 6 weeks or more).
- BMI> 40.
- Sensitivity to one of the following drugs: Propofol, Fentanyl, Rocuronium, Isoflurane, Morphine, Acetaminophen, Ondansetron.
Sites / Locations
- Tel-Aviv Sourasky Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
No Intervention
Active Comparator
No Intervention
Group A
Group B
Group C
Group D
American Society of Anesthesiologists (ASA) Score 2-3 with chronic use of Beta adrenergic receptor blockers planned to undergo total hip replacement
American Society of Anesthesiologists (ASA) Score 2-3 with no chronic use of Beta adrenergic receptor blockers planned to undergo total hip replacement
American Society of Anesthesiologists (ASA) Score 2-3 with chronic use of Beta adrenergic receptor blockers planned to undergo total knee replacement.
American Society of Anesthesiologists (ASA) Score 2-3 with no chronic use of Beta adrenergic receptor blockers planned to undergo total knee replacement